Transgenic expression of AOX in mammalian systems has been suggested as a therapeutic option for treating mitochondrial disease induced by OXPHOS dysfunction39, and additionally it has been shown that even broad expression of AOX does not disturb normal physiology in mice40. The gene discussed is ACOX1; the disease is inborn mitochondrial metabolism disorder.